# Rui Qian

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rui-qian

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.ruiqian-tech.com
- Latest round: Angel (Oct 9, 2018)
- Investors on record: 2

## About

Established in 2017 and based in Suzhou, China, Rui Qian operates as a cervical cancer diagnostic equipment developer that focuses on the diagnosis of cervical cancer cells via artificial intelligence. The company's core team acquired the Suzhou High-tech Zone Leading Talent Award and the Jiangsu Province Double Entrepreneurship Talent Award. Founder Xu Zhang was formerly the CEO/CTO of Yaneng Biotechnology (Shenzhen) Co., Ltd. In October 2018, the company closed an angel funding from Bohe Angel Fund and Guoqian Venture Capital.

The company is committed to applying machine vision to medical intelligent diagnosis and industrial intelligent testing. It has developed cervical cancer exfoliated cell assisted diagnosis products, including cervical cell AI-assisted diagnosis systems, high-speed slide scanners, and liquid-based thin-layer cell slicing machines. For the industrial field, the company also provides industrial testing equipment products.

The company generates revenue by providing cervical cancer cell screening products and artificial intelligence (AI) assisted diagnosis system.

## Funding rounds

- Angel, Oct 9, 2018 — Bohe Angel Fund, Guoqian Venture Capital

## Investors

- Bohe Angel Fund — Angel
- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Angel